Navigation Links
DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast
Date:12/5/2008

QUEBEC CITY, Dec. 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced today that the Company will release its fourth quarter and fiscal 2008 year end results on December 17, 2008, at approximately 5:00 p.m. (ET). This release will be followed by a conference call, which will be held on December 18, 2008, at 10:30 a.m. (ET). The conference will begin with a brief presentation, followed by a question-and-answer period.

The event will be webcast live through DiagnoCure's website at www.diagnocure.com, through a link on the Investors page - Presentations and Conferences.

For those who wish to take part in the conference call for the Q&A period, please dial (514) 807-8791 (Montreal area), (416) 644-3416 (Toronto area) or the toll-free number (800) 732-9307.

For those unable to participate, a replay of the audio conference will also be available on DiagnoCure's website as of December 19, 2008, also through a link on the Investors page - Presentations and Conferences.

About DiagnoCure

DiagnoCure (TSX: CUR) is a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services that increase clinician and patient confidence in making critical treatment decisions. DiagnoCure Oncology Laboratories, a subsidiary of DiagnoCure Inc., recently launched the Previstage(TM) GCC Colorectal Cancer Staging Test, the first GCC-based molecular test for the management of colorectal cancer. The Company also has a strategic alliance with Gen-Probe (NASDAQ: GPRO) for the development and commercialization of a second-generation prostate cancer test using PCA3, DiagnoCure's proprietary molecular marker. Thi
'/>"/>

SOURCE DIAGNOCURE INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. DiagnoCure to webcast presentation at the Piper Jaffray Health Care Conference on December 3, 2008
2. DiagnoCure to present at the JMP Securities Healthcare Focus Conference on October 6, 2008
3. Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test
4. DiagnoCures GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group
5. DiagnoCure announces second quarter 2008 results
6. DiagnoCure to host Q2 2008 earnings conference call and webcast
7. DiagnoCures molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings
8. Susan G. Komen for the Cure(R) Announces Recipients of 2008 Komen Brinker Award for Scientific Distinction
9. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
10. OneMedPlace announces panels for "OneMedForum 2009: Disrupters and Drivers in Eight Areas of Medical Technology" -- CEOs and investors to meet in unique format of focused sessions
11. Integrated Healthcare Holdings, Inc. Announces New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 (HealthDay News) -- Even though its use is often ... Tylenol -- does not help treat lower back pain, according ... the drug was no more effective than a dummy pill ... pain. Besides showing no effect in easing discomfort, the ... sleep woes tied to back pain, nor did it improve ...
(Date:7/24/2014)... Attendances at emergency departments can be reduced by enabling ... visit their doctor,s surgery. This is just one of ... by researchers at the University of Bristol. , Called ... of systematic reviews, the report has been compiled by ... who looked at evidence from studies around the world. ...
(Date:7/24/2014)... have identified two previously undescribed radiological signs ... gastric bands. Adding widespread knowledge of the ... margin by more than 2.4 cm from ... air-fluid,level above the band on a frontal ... in diagnosing affected bariatric patients. These signs ...
(Date:7/24/2014)... Insecticides similar to nicotine, known as neonicotinoids, were ... to a new USGS study. This is the ... Midwestern United States and one of the first ... killing a broad range of insect pests, use ... last decade across the United States, particularly in ...
(Date:7/24/2014)... The National Resident Matching Program (NRMP) ... version of its smartphone app, The MATCH Program Rating ... in NRMP’s Main Residency Match® and Specialties Matching Service®. ... information during the interview process and develop program ratings ... lists. Rank order lists are used by the ...
Breaking Medicine News(10 mins):Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 2Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 3Health News:Seeing the same GP at every visit will reduce emergency department attendance 2Health News:Corn & soy insecticides similar to nicotine found widespread in Midwest rivers -- USGS news 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 3
... (NAFLD) have suboptimal levels of cardiovascular fitness, muscle strength, ... study. The findings appear in the April issue of ... Study of Liver Diseases (AASLD). The article is also ... , About one-in-four U.S. adults suffers from NAFLD, which ...
... Attributes encouraged in the trials process may improve overall ... -- Patients with heart attacks or other acute heart ... rates in hospitals that take part in clinical trials, ... than 174,000 patients with two types of heart conditions ...
... offering the best for its gifted students and staff members,Stanford ... machines, which are geared towards natural and ... of Solana Beach, Ca,YoNaturals Inc. was launched in August of ... have been committed, from the start, to providing,its customers with ...
... for Healthcare ... Professionals, HADDON ... malignant type of glioma. Healthcare professionals,face many challenges in the treatment ... in patients is less than,one year., Recent clinical trials have ...
... Mass., March 24 Andover,Medical, Inc. (OTC Bulletin Board: ... ("DME"), announced today that the,Company anticipates closing a $2.0 ... of the financing can be,found in the Company,s Form ... and,available at http://www.sec.gov ., On March 13, ...
... -- Heart damage due to blocked arteries remains the leading ... a Florida State University College of Medicine researcher is helping ... Blaber, a professor in the department of biomedical sciences, is ... shown to help the human body grow new blood vessels ...
Cached Medicine News:Health News:Study finds certain liver disease related to cardiovascular fitness 2Health News:Patients Do Better at Hospitals With Clinical Trials 2Health News:YoNaturals to Install Healthy Vending Machines at Stanford University 2Health News:Adult Glioblastoma: Strategies, Challenges, and Opportunities 2Health News:Andover Medical, Inc. Anticipates Closing $2.0 Million Private Financing 2Health News:Andover Medical, Inc. Anticipates Closing $2.0 Million Private Financing 3Health News:FSU researcher's 'mutant' proteins could lead to new treatment for heart disease 2
(Date:7/24/2014)...  Bruin Biometrics (BBI), a pioneer in biometric-sensor ... weeks of clinical briefings to over 200 pressure ... substantial concurrence on both the clinical validity of ... BBI,s SEM Scanner. "From our ... drawn from the European Wound Management Association (EWMA) ...
(Date:7/24/2014)... -- As part of its ongoing effort to help women pharmacists ... Ownership Boot Camp on July 26 as part of the ... D.C. The Boot Camp is designed ... own their own pharmacies.  Now in its third year, the ... women pharmacists who dream of owning a pharmacy.   ...
(Date:7/24/2014)... 2014 Lpath, Inc. (NASDAQ: ... therapeutics, reported interim results in a Phase 2a ... as a treatment for metastatic renal cell carcinoma ... one therapy involving a VEGF inhibitor (e.g., Sutent®/ ... inhibitor (e.g., Afinitor®/everolimus), with a maximum of three ...
Breaking Medicine Technology:Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 4Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4
... SHANGHAI, Feb. 21, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... leading China-based pharmaceutical and biotechnology research and development outsourcing ... Annual Health Care Conference, to be held in Boston, ... Xie, Vice President of Finance and Investor Relations of ...
... 2012  NewCrop LLC has selected Verizon Enterprise ... NewCrop,s new electronic system for prescribing controlled ... tailored digital identity solution, Verizon Universal ... submit electronic prescriptions for controlled substances via ...
Cached Medicine Technology:NewCrop Chooses Verizon to Help Provide Secure Electronic Prescriptions for Controlled Substances 2NewCrop Chooses Verizon to Help Provide Secure Electronic Prescriptions for Controlled Substances 3
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique to be used in left hand. Round knurled handle....
Flat 7 mm wide hook. Flat serrated handle with polished finish. Overall length: 5.1 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Medicine Products: